CLC-KB inhibitors represent a diverse chemical class of compounds specifically designed and employed in laboratory research to investigate the physiological functions and underlying mechanisms of the CLC-Kb chloride channel. CLC-Kb, or chloride channel Kb, is a member of the CLC family of chloride channels and transporters, which play critical roles in maintaining cellular chloride homeostasis. These inhibitors are instrumental tools for elucidating the functional properties of CLC-Kb channels and their involvement in chloride ion transport across biological membranes. By selectively blocking CLC-Kb activity, researchers can gain insights into the channel's biophysical characteristics and its impact on cellular processes.The chemical structures and properties of CLC-Kb inhibitors can vary widely, but they all share the common feature of interfering with the normal functioning of CLC-Kb channels. Mechanistically, these inhibitors are designed to target specific regions or binding sites within the channel protein, disrupting its ability to facilitate the movement of chloride ions across cell membranes.
Some inhibitors, such as Niflumic acid and DIDS (4,4'-Diisothiocyanatostilbene-2,2'-disulfonic acid), block the ion-conducting pathway of CLC-Kb, preventing chloride ions from passing through. Others, like NS3736 and Benzamil, interfere with the channel's gating properties, altering its open and closed states. This diversity in inhibition mechanisms allows researchers to tailor their experimental approaches and better understand how CLC-Kb contributes to cellular chloride transport and ion balance.CLC-Kb inhibitors constitute a chemically diverse class of compounds essential for scientific investigations aimed at uncovering the intricacies of CLC-Kb chloride channels. These inhibitors serve as invaluable tools for dissecting the channel's biophysical properties and its role in chloride ion transport processes within cells. By selectively perturbing CLC-Kb function, researchers can advance their knowledge of cellular physiology and gain a deeper understanding of the physiological relevance of this particular chloride channel in various biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Niflumic acid inhibits CLC-Kb by blocking chloride currents through the channel, preventing chloride ion transport. It also reduces channel expression. | ||||||
Benzamil•HCl | 161804-20-2 | sc-201070 | 50 mg | $195.00 | 1 | |
Benzamil is a selective inhibitor of CLC-Kb that works by blocking chloride ion transport through the channel. | ||||||
5-Nitro-2-(3-phenylpropylamino)benzoic Acid (NPPB) | 107254-86-4 | sc-201542 sc-201542B sc-201542A | 10 mg 25 mg 50 mg | $109.00 $193.00 $317.00 | 7 | |
NPPB inhibits CLC-Kb by binding to the channel's anion-conducting pathway and reducing chloride current. | ||||||
Clofibric acid | 882-09-7 | sc-203000 sc-203000A | 10 g 50 g | $24.00 $40.00 | 1 | |
Clofibric acid inhibits CLC-Kb by interfering with chloride ion transport and modulating channel activity. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $318.00 | 9 | |
Fluoxetine inhibits CLC-Kb by modulating channel activity and reducing chloride ion transport. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $53.00 $88.00 | 6 | |
Ibuprofen inhibits CLC-Kb by reducing chloride current through the channel and affecting channel gating properties. | ||||||